腹泻型肠易激综合征,Diarrhea-predominant irritable bowel syndrome英语短句,例句大全

腹泻型肠易激综合征,Diarrhea-predominant irritable bowel syndrome
1)Diarrhea-predominant irritable bowel syndrome腹泻型肠易激综合征
1.The physical difference is not only the key to determine the occurrence of diarrhea-predominant irritable bowel syndrome,but also to determine the varieties of physique type.体质差异不但是决定腹泻型肠易激综合征发病与否的关键,也决定其各种质型。
2.Objective To observe the curative effect of Jiawei Tongxie decoction in treating diarrhea-predominant irritable bowel syndrome.目的观察加味痛泻要方治疗腹泻型肠易激综合征的疗效。

英文短句/例句

1.Inducing of irritable bowel syndrome with diarrhea in rats腹泻型肠易激综合征大鼠模型的建立
2.Clinical Observation of Treatment Determination from Liver and Spleen on Diarrhea-Predominate Irritable Bowel Syndrome,A Report of 30 Cases从肝脾论治腹泻型肠易激综合征30例
3.The Expression of Aquaporin4 and Aquaporin8 in Human Colon in the Diarrhea-Predominant Irritable Bower Syndrome.;腹泻型肠易激综合征结肠粘膜AQP4、AQP8表达的研究
4.The Observation of Additive ShenLingBaiZhu Decoction s Curative Effect in Treating Diarrhea Type Irritable Colon Syndrome (IBS-D) Which Belongs to the Type of Weakness of Spleen;参苓白术散加减治疗腹泻型肠易激综合征
5.Clinical Observation of Syndrome Differentiation and Treatment for 60 Cases of Diarrhea-Predominant Irritable Bowel Syndrome辨证治疗腹泻型肠易激综合征60例临床观察
6.Clinical Application of Physique Theory in Diagnosis and Treatment of Diarrhea-predominant Irritable Bowel Syndrome体质学说在腹泻型肠易激综合征诊疗中的应用
7.The Efficiency Observation of Tianjiu Therapy on Irritable Bowel Syndrome of Diarrhea Type天灸疗法治疗腹泻型肠易激综合征疗效观察
8.Clinical Observation on Jiawei Tongxie Decoction in Treating 30 Cases of Diarrhea-predominant Irritable Bowel Syndrome加味痛泻要方治疗腹泻型肠易激综合征30例临床观察
9.The Effect of Tongxie Yaofang Decoction on Cajal Cells in a Rat Model of D-IBS痛泻要方对腹泻型肠易激综合征Cajal间质细胞影响的研究
10.Clinical investigation of Xieganjianpi in treating diarrheal Irritable bowel syndrome泻肝健脾方煎剂治疗腹泻型肠易激综合征的临床研究
11.Shengyang Zhixie Decoction Treat Diarrhea Irritable Bowel Syndrome(IBS) 89 Cases升阳止泻汤治疗腹泻型肠易激综合征89例疗效观察
12.A Study on Manufacturing Pharmacy and Mechanism of Interference in Diarrhea IBS of Changji'an Capsule;肠激安胶囊制剂学及干预腹泻型肠易激综合征机理研究
13.Mechanicm Research on Yiji Capsule for Treatment of Diarrhea-predominant Irritable Bowel Syndrome Rat Model易激胶囊对腹泻型肠易激综合征大鼠治疗作用机理的研究
14.YIJI Capsule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (Liver Stagnation and Spleen Deficiency) Clinical Study易激胶囊治疗腹泻型肠易激综合征（脾虚肝郁证）的临床研究
15.Clinical observation of treating diarrhea-predominant irritable bowel syndrome(D-IBS) with Lichang Tang(Intestine-Regulating Decoction) and sertraline hydrochloride理肠汤合盐酸舍曲林治疗腹泻型肠易激综合征疗效观察
16.Screening and Identification of Abnormal Expression Proteins from the Colon in Diarrhea-predominant Irritable Bowel Syndrome;腹泻型肠易激综合征患者结肠异常表达蛋白质的筛选及鉴定
17.Screening and Identification of Colon Mucosal Proteins in Patients with Irritable Bowel Syndrome with Diarrhea;腹泻型肠易激综合征患者结肠黏膜蛋白质的筛选与鉴定
18.Immediate Effect of Acupuncture on Colon Motility in Patients with IBS-Diarrhea针刺对腹泻型肠易激综合征患者结肠蠕动的即时效应观察

相关短句/例句

Diarrhea irritable bowel syndrome腹泻型肠易激综合征
1.[Methods]To select patients of excerpt diarrhea irritable bowel syndrome and constipation irritable bowel syndrome and divide them into two group:one is called treatment group and other is called comparison group.[方法]选择腹泻型肠易激综合征与便秘型肠易激综合征患者分别分成治疗组和对照组,治疗后进行疗效观察,各型组间进行统计学分析。
3)diarrhea-predominate irritable bowel syndrome腹泻型肠易激综合征
1.Objective:To observe the curative effect of treatment determination from liver and spleen on diarrhea-predominate irritable bowel syndrome.目的:观察从肝脾论治腹泻型肠易激综合征的临床疗效。
4)Women Diarrhea-predominant irritable bowel syndrome女性腹泻型肠易激综合征
5)Irritable bowel syndrome with constipation肠易激综合征便秘型
6)IBS-C便秘型肠易激综合征
1.Objective To evaluate the clinical efficacy on constipation-dominant irrtable bowel syndrome(IBS-C) treated on-demand with tegaserod combined with medilac-s in improving patients stool description,clinical symptom and quality of life.目的探讨替加色罗联合微生态制剂按需给药治疗便秘型肠易激综合征(constipation-dominant irritable bowel syndrome,IBS-C)的临床疗效和可行性。
2.Objective To evaluate the clinical efficacy on constipation-dominant irrtable bowel syndrome(IBS-C)treated with Zhishu decoction.目的探讨《金匮》枳术汤加减治疗便秘型肠易激综合征(constipation-dominant irritable bowel syndrome,IBS-C)的临床疗效。
3.Objective: To study the clinical effect on C-irrtable bowel syndrome (IBS-C) treated on-demand with tegaserod combined with medilac-s in improving patients stool description, clinical symptom and quality of life.目的在应用替加色罗(商品名：泽马可)联合微生态制剂(商品名：美常安)治疗便秘型肠易激综合征过程中，通过对按需给药与系统给药两种治疗方式在改善患者大便性状、临床症状及生活质量方面的治疗效果进行比较，评价按需给药方式的有效性，从而探讨按需给药治疗的可行性，为临床治疗方案的制定提供一定参考。